Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Supervillin family member 2, pseudogene (SVIL2P) is classified as a pseudogene related to the supervillin gene family. Pseudogenes are non-functional DNA sequences derived from ancestral genes; they generally do not encode functional protein products. While some pseudogenes in the human genome may have regulatory roles—such as generating small RNAs or influencing gene expression by serving as decoys for microRNAs—SVIL2P does not encode a protein and has no known biological activity or established involvement in human disease or clinical pharmacology. Its only reported aliases are SVIL2P and SVILP1, and it resides in the genome as a non-coding sequence[4][3][6].\n\nKey points:\n- SVIL2P is not a receptor, enzyme, transporter, transcription factor, or any other classical drug target.\n- It is a pseudogene, a non-functional genomic remnant.\n- There is no evidence SVIL2P is involved in disease or therapy; it is not studied as a drug target or biomarker[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Supervillin family member 2, pseudogene (SVIL2P).